Join to View Full Profile
10833 Le Conte Avenue43-229 CHSLos Angeles, CA 90095
Phone+1 310-267-2725
Fax+1 310-267-2725
Dr. Dubinett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard Medical SchoolFellowship, Cancer Immunology, 1986 - 1988
Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolResidency, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1981 - 1984
Rutgers Health/New Jersey Medical SchoolInternship, Internal Medicine, 1980 - 1981- Rutgers New Jersey Medical SchoolClass of 1980
Certifications & Licensure
CA State Medical License 1981 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy Start of enrollment: 2007 Mar 30
- DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules Start of enrollment: 2013 Jan 01
- DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers Start of enrollment: 2020 Aug 24
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy.Michael S Oh, Jensen Abascal, Austin K Rennels, Ramin Salehi-Rad, Steven M Dubinett
Cancers. 2025-03-19 - Translating premalignant biology to accelerate non-small-cell lung cancer interception.Sarah A Mazzilli, Zahraa Rahal, Maral J Rouhani, Sam M Janes, Humam Kadara
Nature Reviews. Cancer. 2025-02-24 - Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer.Michael S Oh, Camelia Dumitras, Ramin Salehi-Rad, Linh M Tran, Kostyantyn Krysan
Molecular Cancer Therapeutics. 2025-02-04
Journal Articles
- Functional Profiling of Circulating Tumor Cells with an Integrated Vortex Capture and Single-Cell Protease Activity AssaySteven M Dubinett, Matthew B Rettig, Proceedings of the National Academy of Sciences
Press Mentions
UCLA Receives $20 Million from Saul and Joyce Brandman Foundation for New Lung Health CenterMarch 6th, 2025- UCLA’s Dr. Donna Washington Elected to the National Academy of MedicineOctober 21st, 2024
- Genetically Engineered Dendritic Cells Enhance the Power of Immunotherapy Against Lung CancerMarch 26th, 2024
- Join now to see all
Grant Support
- Evaluation of PARP7 dependency as a novel therapeutic target for non-small cell lung cancerVA GREATER LOS ANGELES HEALTHCARE SYSTEM2024–2028
- UCLA Tumor Immunology Institutional Training GrantUNIVERSITY OF CALIFORNIA LOS ANGELES1980–2028
- UCLA Tumor Immunology Institutional Training GrantUNIVERSITY OF CALIFORNIA LOS ANGELES1980–2028
- The Boston University - UCLA Lung Cancer Biomarker Characterization CenterBOSTON UNIVERSITY MEDICAL CAMPUS2022–2027
- UCLA Clinical and Translational Science InstituteUNIVERSITY OF CALIFORNIA LOS ANGELES2016–2027
- The Lung PCA: A Multi-Dimensional Atlas of Pulmonary PremalignancyBOSTON UNIVERSITY MEDICAL CAMPUS2018–2025
- UCLA Pulmonary and Critical Care Medicine Training ProgramUNIVERSITY OF CALIFORNIA LOS ANGELES2003–2025
- Intratumoral Genetic Therapy For Lung CancerVeterans Affairs2012
- Inflammation In The Pathogenesis Of Lung CancerVeterans Affairs2011–2012
- UCLA Clinical And Translational Science InstituteNational Center For Research Resources2011
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2011
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2011
- The UCLA - Boston University Lung Cancer Biomarker Development LaboratoryNational Cancer Institute2010–2011
- Thoracic OncologyNational Cancer Institute2009–2011
- Novel COX-2 And Pge2-Dependent Pathways In Lung CancerNational Cancer Institute2006–2010
- UCLA Spore In Lung CancerNational Cancer Institute2001–2008
- A Phase I Trial Of Ccl-21 Gene Modified DC In NsclcNational Cancer Institute2003–2007
- New Pathways In IL7 Mediated Antifibrotic ResponsesNational Heart, Lung, And Blood Institute2002–2005
- Genetic Immunotherapy For Lung CancerNational Cancer Institute2001–2004
- Dendritic Cell-Based Genetic Immunotherapy /Lung CancerNational Cancer Institute2001–2002
- New Pathways In IL7 Mediated Antifibrotic ResponsesNational Heart, Lung, And Blood Institute2001
- Function And Regulation Of IL 10 In Lung CancerNational Cancer Institute1997–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
